Notice NOT-AI-21-080 from the NIH Guide for Grants and Contracts

Notice NOT-AI-21-081 from the NIH Guide for Grants and Contracts

Notice NOT-DA-21-089 from the NIH Guide for Grants and Contracts

Notice NOT-CA-22-002 from the NIH Guide for Grants and Contracts

Notice NOT-DK-21-015 from the NIH Guide for Grants and Contracts

£42,527-£50,942 per annum: https://jobs.sanger.ac.uk/vacancy/senior-software-developers-461812.html: Two opportunities have arisen to join our world leading software development and bioinformatics team at the Wellcome Sanger Institute just outside ... Cambridge, Cambridgeshire

Funding Opportunity RFA-NS-21-025 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIH Blueprint for Neuroscience Research R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. This FOA solicits Research Education Grant (R25) applications to develop and implement short courses on neurotherapeutics development for academic neuroscientists. The short courses should provide participants with a sufficient overview of the neurotherapeutics development process to (1) understand the steps required for therapeutics development, (2) anticipate and overcome common challenges in the process, and (3) interact effectively with collaborators who have expertise in various aspects of therapeutics development. The short courses should primarily target independent academic neuroscience researchers and senior post-doctoral fellows interested in incorporating treatment development into their research programs.

Notice NOT-DA-21-086 from the NIH Guide for Grants and Contracts

£60000 - £80000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Manager to join a n exciting multi cultural biotech based in the Cambridge area. As the Bioinformatics Manager... Cambridge

£40000 - £60000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Scientist to join a leading biotech company based in the Cambridge area. As the Bioinformatics Scientist you will... Cambridgeshire

£40000 - £50000 per annum: Hyper Recruitment Solutions (HRS): We are currently looking for a Bioinformatics Pipeline Developer to join a leading Biotech company based in the Cambridgeshire area. As the Bioinformatics Pipeline Developer... Cambridge

Funding Opportunity RFA-AI-21-070 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support discovery and design of novel Group A Streptococcus (GAS) vaccine candidates and their advancement into preclinical evaluation for broad protection against GAS infections.

Notice NOT-OD-22-010 from the NIH Guide for Grants and Contracts

Notice NOT-HL-23-002 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AT-22-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages UG3/UH3 phased cooperative research applications to conduct efficient, large-scale pragmatic trials or implementation studies that focus on improving health outcomes for underserved US patient populations. Awards made under this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible transition to an implementation phase (UH3). UG3 projects that have met the scientific milestone and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The overall goal of this initiative is to support the "real world" assessment of health care strategies and clinical practices and procedures in health care systems (HCS) that lead to improved care for underserved populations; who have suffered a disproportionate disease burden in the US. Results from the pragmatic studies supported by this FOA should inform policy makers, payers, doctors and patients across diverse patient care settings. This FOA requires that the intervention under study be embedded into health care delivery system, real world settings. Studies can propose to integrate multi-modal or multiple interventions that have demonstrated efficacy into HCS; or implement HCS changes to improve adherence to evidence-based guidelines. Trials or studies should be conducted across three or more health care systems (HCS) that provide care to underserved patient populations; and will become part of and work with the NIH HCS Research Collaboratory. The NIH HCS Research Collaboratory Program has established a Collaboratory Coordinating Center (CCC) that is providing national leadership and technical expertise in all aspects of research with HCS (See Companion FOA).

Competitive Salary: EMBL: RNAcentral is a leading database for non-coding RNA sequences. This resource is visited by tens of thousands of users every year, is highly cited and Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: We are looking to recruit a Community Outreach Officer for Europe PMC to work within the Literature Services team at the European Bioinformatics Insti Europe

Competitive Salary: EMBL: ELIXIR is seeking an enthusiastic and collaborative self-starter to join us as an Industry Officer. You will be joining the External Relations team w Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: The Bork group is seeking a highly motivated bioinformatics software engineer to collaboratively design, build, and run data analysis workflows for mi Germany (DE)

Competitive Salary: EMBL: We are seeking a highly motivated computational biologist to join the research group of Peer Bork within the Structural and Computational Biology Unit Germany (DE)